| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.
|
JAMA
|
2007
|
7.93
|
|
2
|
A retrograde-viewing device improves detection of adenomas in the colon: a prospective efficacy evaluation (with videos).
|
Gastrointest Endosc
|
2009
|
5.38
|
|
3
|
Colorectal cancer in patients under close colonoscopic surveillance.
|
Gastroenterology
|
2005
|
4.31
|
|
4
|
Results of repeat sigmoidoscopy 3 years after a negative examination.
|
JAMA
|
2003
|
3.82
|
|
5
|
A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.
|
Gastroenterology
|
2006
|
3.35
|
|
6
|
A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas.
|
N Engl J Med
|
2015
|
2.88
|
|
7
|
Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial.
|
Lancet
|
2008
|
2.83
|
|
8
|
Folic acid and risk of prostate cancer: results from a randomized clinical trial.
|
J Natl Cancer Inst
|
2009
|
2.64
|
|
9
|
Mucins and mucin binding proteins in colorectal cancer.
|
Cancer Metastasis Rev
|
2004
|
2.64
|
|
10
|
Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.
|
J Natl Cancer Inst
|
2005
|
2.27
|
|
11
|
Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward.
|
Clin Cancer Res
|
2006
|
2.24
|
|
12
|
Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.88
|
|
13
|
Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps.
|
Cancer Prev Res (Phila)
|
2012
|
1.65
|
|
14
|
Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs.
|
Mol Cell Biol
|
2004
|
1.63
|
|
15
|
Chromoendoscopy detects more adenomas than colonoscopy using intensive inspection without dye spraying.
|
Cancer Prev Res (Phila)
|
2008
|
1.47
|
|
16
|
Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer.
|
Cancer Res
|
2008
|
1.45
|
|
17
|
Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity.
|
Cancer Res
|
2009
|
1.44
|
|
18
|
A galectin-3 sequence polymorphism confers TRAIL sensitivity to human breast cancer cells.
|
Cancer
|
2011
|
1.42
|
|
19
|
Adherence to the USDA Food Guide, DASH Eating Plan, and Mediterranean dietary pattern reduces risk of colorectal adenoma.
|
J Nutr
|
2007
|
1.37
|
|
20
|
Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination.
|
J Natl Cancer Inst
|
2012
|
1.27
|
|
21
|
Ability of integrated positron emission and computed tomography to detect significant colonic pathology: the experience of a tertiary cancer center.
|
Cancer
|
2010
|
1.25
|
|
22
|
COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett's oesophagus and oesophageal adenocarcinoma.
|
Gut
|
2007
|
1.12
|
|
23
|
Missed adenomas during colonoscopic surveillance in individuals with Lynch Syndrome (hereditary nonpolyposis colorectal cancer).
|
Cancer Prev Res (Phila)
|
2008
|
1.11
|
|
24
|
Galectin-3 modulates MUC2 mucin expression in human colon cancer cells at the level of transcription via AP-1 activation.
|
Gastroenterology
|
2005
|
1.08
|
|
25
|
Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.07
|
|
26
|
Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.
|
J Natl Cancer Inst
|
2009
|
1.05
|
|
27
|
Overexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding Ras and activating Ras signaling.
|
PLoS One
|
2012
|
1.04
|
|
28
|
Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy.
|
Cancer
|
2006
|
1.00
|
|
29
|
CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma.
|
Carcinogenesis
|
2005
|
0.99
|
|
30
|
Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma.
|
Cancer
|
2005
|
0.98
|
|
31
|
Phosphorylated galectin-3 mediates tumor necrosis factor-related apoptosis-inducing ligand signaling by regulating phosphatase and tensin homologue deleted on chromosome 10 in human breast carcinoma cells.
|
J Biol Chem
|
2007
|
0.97
|
|
32
|
Calcium plus vitamin D alters preneoplastic features of colorectal adenomas and rectal mucosa.
|
Cancer
|
2006
|
0.97
|
|
33
|
Phosphorylation of galectin-3 contributes to malignant transformation of human epithelial cells via modulation of unique sets of genes.
|
Cancer Res
|
2005
|
0.97
|
|
34
|
Predictors of advanced proximal neoplasia in persons with abnormal screening flexible sigmoidoscopy.
|
Clin Gastroenterol Hepatol
|
2003
|
0.95
|
|
35
|
Gastrointestinal complications of oncologic therapy.
|
Nat Clin Pract Gastroenterol Hepatol
|
2008
|
0.95
|
|
36
|
Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial.
|
J Clin Endocrinol Metab
|
2014
|
0.95
|
|
37
|
Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
0.94
|
|
38
|
Identification and characterization of functional risk variants for colorectal cancer mapping to chromosome 11q23.1.
|
Hum Mol Genet
|
2013
|
0.93
|
|
39
|
Calcium intake and colorectal adenoma in a US colorectal cancer early detection program.
|
Am J Clin Nutr
|
2004
|
0.93
|
|
40
|
Smoking-associated risks of conventional adenomas and serrated polyps in the colorectum.
|
Cancer Causes Control
|
2014
|
0.93
|
|
41
|
Up-regulation of neogenin-1 increases cell proliferation and motility in gastric cancer.
|
Oncotarget
|
2014
|
0.92
|
|
42
|
Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent colorectal adenomas.
|
J Natl Cancer Inst
|
2009
|
0.92
|
|
43
|
Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
0.92
|
|
44
|
Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics.
|
Ann Intern Med
|
2009
|
0.92
|
|
45
|
Adherence to repeat screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
|
Cancer
|
2002
|
0.91
|
|
46
|
Digestive cancer management in Asia: position statements: a report on GI Oncology Summit in 2011.
|
J Gastroenterol Hepatol
|
2012
|
0.90
|
|
47
|
The gastrointestinal complications of oncologic therapy.
|
Gastroenterol Clin North Am
|
2010
|
0.90
|
|
48
|
Alternative splicing of the human MUC2 gene.
|
Arch Biochem Biophys
|
2004
|
0.88
|
|
49
|
Epidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cells.
|
Cancer
|
2010
|
0.87
|
|
50
|
Vitamin D3 supplementation and upper respiratory tract infections in a randomized, controlled trial.
|
Clin Infect Dis
|
2013
|
0.86
|
|
51
|
Adenoma detection in patients undergoing a comprehensive colonoscopy screening.
|
Cancer Med
|
2013
|
0.86
|
|
52
|
Polyphenon E inhibits the growth of human Barrett's and aerodigestive adenocarcinoma cells by suppressing cyclin D1 expression.
|
Clin Cancer Res
|
2009
|
0.85
|
|
53
|
Clinical management of hereditary colorectal cancer syndromes.
|
Curr Opin Gastroenterol
|
2004
|
0.84
|
|
54
|
Bile acids induce MUC2 overexpression in human colon carcinoma cells.
|
Cancer
|
2005
|
0.84
|
|
55
|
Polymorphisms in the adenomatous polyposis coli (APC) gene and advanced colorectal adenoma risk.
|
Eur J Cancer
|
2010
|
0.82
|
|
56
|
Hemochromatosis gene mutations and distal adenomatous colorectal polyps.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
0.82
|
|
57
|
Alterations in gastric mucin synthesis by Helicobacter pylori.
|
World J Gastroenterol
|
2000
|
0.82
|
|
58
|
Chemoprevention of colorectal neoplasia: advances and controversies (the COX-2 story).
|
Curr Opin Gastroenterol
|
2007
|
0.81
|
|
59
|
Impact of cyclin D1 A870G polymorphism in esophageal adenocarcinoma tumorigenesis.
|
Semin Oncol
|
2005
|
0.81
|
|
60
|
Induction of MUC5AC mucin by conjugated bile acids in the esophagus involves the phosphatidylinositol 3-kinase/protein kinase C/activator protein-1 pathway.
|
Cancer
|
2010
|
0.78
|
|
61
|
Dysplasia in Barrett esophagus.
|
Cancer
|
2004
|
0.78
|
|
62
|
Expression of human intestinal mucin is modulated by the beta-galactoside binding protein galectin-3 in colon cancer.
|
Gastroenterology
|
2002
|
0.77
|
|
63
|
CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment.
|
Cancer Causes Control
|
2012
|
0.77
|
|
64
|
Diagnostic evaluation of patients with a high suspicion of malignancy: comorbidities and clinical predictors of cancer.
|
Am J Med Sci
|
2005
|
0.76
|
|
65
|
CRC screening, past, present, and future: a tribute to Emmet Keeffe.
|
Dig Dis Sci
|
2015
|
0.76
|
|
66
|
Rectal mucosal quantitative galactose oxidase-Schiff reaction as an early detection biomarker for colorectal cancer: comparison to fecal occult stool blood test.
|
Cancer Biomark
|
2011
|
0.75
|
|
67
|
Large intestine.
|
Curr Opin Gastroenterol
|
2003
|
0.75
|
|
68
|
Intestinal mucin and colorectal cancer: it's not just goo.
|
Gastroenterology
|
2002
|
0.75
|
|
69
|
Aspirin and the prevention of colorectal neoplasia.
|
Gastroenterology
|
2003
|
0.75
|
|
70
|
Primary chemoprevention of familial adenomatous polyposis with sulindac: more questions than answers.
|
Gastroenterology
|
2002
|
0.75
|
|
71
|
Chemoprevention of intestinal polyposis by COX-2 inhibition: from mouse to man.
|
Gastroenterology
|
2002
|
0.75
|